Home
GoodRx Holdings GDRX paid Continental Strategy $90K for lobbying in Q4 2025 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $90,000
- Quarter
- Q4 2025
- Stock
- GoodRx Holdings GDRX
- Client
- Goodrx
- Reported
- 26/01/19
Up 0.0% from last quarter
What else happened in GoodRx Holdings around then
Filed or reported within 30 days of the trade day · 25/12/01~01/30Goodrx's other lobbying reports
- Goodrx
LobbyingGoodRx Holdings
LobbyingGoodRx Holdings
GDRX
$60K
$60K
Reported 07/20
for Q2
- Goodrx
LobbyingGoodRx Holdings
LobbyingGoodRx Holdings
GDRX
$380K
$380K
Reported 07/20
for Q2
- Goodrx
LobbyingGoodRx Holdings
LobbyingGoodRx Holdings
GDRX
$90K
$90K
Reported 07/19
for Q2
- Goodrx
LobbyingGoodRx Holdings
LobbyingGoodRx Holdings
GDRX
$80K
$80K
Reported 07/17
for Q2
- Goodrx
LobbyingGoodRx Holdings
LobbyingGoodRx Holdings
GDRX
$60K
$60K
Reported 04/21
for Q1